J.J. Collins received a bachelor's degree in Physics (summa cum laude; class valedictorian) from the College of the Holy Cross in 1987 and a doctorate in Medical Engineering from the University of Oxford in 1990. From 1987 to 1990, he was a Rhodes Scholar. Since 1990, he has been a faculty member in the Department of Biomedical Engineering at Boston University. Currently, Dr. Collins is a University Professor, Professor of Biomedical Engineering, and Co-Director of the Center for BioDynamics at Boston University. His research interests include: (1) systems biology - reverse engineering naturally occurring gene regulatory networks, and (2) synthetic biology - modeling, designing and constructing synthetic gene networks.

Dr. Collins has received a number of awards and honors, including the American Society of Biomechanics Young Scientist Award, the Thomas Stephen Group Prize from the Engineering in Medicine Group of the Institute of Mechanical Engineers, the Engineering in Medicine and Biology Society Early Career Achievement Award, Boston University's Metcalf Cup and Prize for Excellence in Teaching, and being selected for Technology Review's inaugural TR100 - 100 young innovators who
will shape the future of technology. Dr. Collins is a Fellow of the American Physical Society, the Institute of Physics and the American Institute for Medical and Biological Engineering. In 2003, he received a MacArthur Foundation "Genius Award", and in 2005, he was selected for the Scientific American 50 - the top 50 outstanding leaders in science and technology. In 2007, Dr. Collins received the NIH Director's Pioneer Award and the Ellison Medical Foundation Senior Scholar Award in Aging. This past year, Dr. Collins was selected as a Howard Hughes Medical Institute Investigator, becoming the first BU faculty to be honored with this distinction.

Dr. Collins has been involved with a number of start-up companies, and his inventions and technologies have been licensed by several biotech and medical devices companies. Dr. Collins currently co-chairs the Scientific Advisory Board (SAB) of Gene Network Sciences, and serves on the SAB of Codon Devices, Epitome Biosystems and Joule Biotechnologies; additionally, he has served on the SAB of MannKind Corporation (Nasdaq: MNKD) and Bios Group Inc. Dr. Collins is also a science advisor for Excel Medical Ventures, PureTech Ventures, and Xconomy.